The Wound Microbiology and the Outcomes of the Systemic Antibiotic Prophylaxis in a Mass Burn Casualty Incident
Overview
Authors
Affiliations
This paper describes the wound microbiology and outcome of using systemic antibiotic prophylaxis (SAP) in mass burn casualties (MBC). The charts of 31 patients (mean age: 21 years, mean burn area: 42% of the total body surface area) injured in a dust explosion were reviewed for 1 month after the burn. Polymicrobial and rare pathogen wound infections (Acinetobacter junii, Aeromonas sobri, et al) were common in MBC due to sterility breech. Following the use of SAP for 2 to 14 days after admission, there was a reduction in wound infection rate from 45% at week 1 postburn to 10% at week 4. In addition, no blood stream infection occurred in the first week after the burns. Multidrug-resistant Acinetobacter baumannii, Klebsiella pneumoniae, and Candida albicans were the top three wound pathogens cultured. Multidrug-resistant microorganism infections were found in 39% of the patients, and the odds ratios for the these infections in burn patients with more than ≥40% total body surface area and in patients receiving two or more classes of antibiotics were 41.7 (95% confidence interval [CI] = 2.1-810.7, P = .01) and 9.9 (95% CI= 1.0-92.7, P = .04), respectively. Although SAP did not prevent wound or blood stream infections, no mortality occurred in our patients. A randomized controlled study is needed to investigate the impact of SAP on burn mortality in MBC.
Alharbi A Saudi Med J. 2022; 43(12):1373-1382.
PMID: 36517049 PMC: 9994516. DOI: 10.15537/smj.2022.43.12.20220681.
Cicuttin E, Sartelli M, Scozzafava E, Tartaglia D, Cremonini C, Brevi B Antibiotics (Basel). 2022; 11(2).
PMID: 35203743 PMC: 8868174. DOI: 10.3390/antibiotics11020139.
Puca V, Marulli R, Grande R, Vitale I, Niro A, Molinaro G Antibiotics (Basel). 2021; 10(10).
PMID: 34680743 PMC: 8532735. DOI: 10.3390/antibiotics10101162.
Topical odour management in burn patients.
Hayashida K, Yamakawa S Burns Trauma. 2021; 9:tkab025.
PMID: 34458382 PMC: 8389170. DOI: 10.1093/burnst/tkab025.